Aptose Biosciences Inc.
USD1.71
+1.71 (+100.00%)
CEO
William G. Rice
IPO Date
1992-03-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
Open
$1.71
Prev. Close
$1.71
Day Low
$1.71
Day High
$1.71
52W Low
$1.10
52W High
$43.19
Market Cap
$0.00B
Volume
0.65M
| 50,000 |
| $0.25 |
| 7 Feb 2024 | Seizinger Bernd R. | director | A-Award | Acquired | 3,333 | $2.00 |
| 7 Feb 2024 | Vincent Mark D. | director | A-Award | Acquired | 3,333 | $1.97 |
| 7 Feb 2024 | Whitehead Warren | director | A-Award | Acquired | 3,333 | $1.97 |
| 7 Feb 2024 | PLATZER ERICH | director | A-Award | Acquired | 3,333 | $2.00 |
| 7 Feb 2024 | BURGER DENIS R | director | A-Award | Acquired | 3,333 | $2.00 |
| 7 Feb 2024 | Bejar Rafael | Sr VP & Chief Medical Officer | A-Award | Acquired | 35,000 | $2.00 |
| 7 Feb 2024 | Payne Fletcher | Sr VP and CFO | A-Award | Acquired | 55,000 | $2.00 |
| 7 Feb 2024 | Rice William G. | director, officer: Chair, President & CEO | A-Award | Acquired | 70,000 | $2.00 |